Skip to content
← Back to this collection

PUBLICATIONS · 25833390

A phase 2 study of bortezomib in combination with ifosfamide/vinorelbine in paediatric patients and young adults with refractory/recurrent Hodgkin lymphoma: a Children's Oncology Group study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Br J Haematol
Publication date
2015 Jul
First author
Horton TM

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Horton TM
      type
      Author
    2. name
      Drachtman RA
      type
      Author
    3. name
      Chen L
      type
      Author
    4. name
      Cole PD
      type
      Author
    5. name
      McCarten K
      type
      Author
    6. name
      Voss S
      type
      Author
    7. name
      Guillerman RP
      type
      Author
    8. name
      Buxton A
      type
      Author
    9. name
      Howard SC
      type
      Author
    10. name
      Hogan SM
      type
      Author
    11. name
      Sheehan AM
      type
      Author
    12. name
      López-Terrada D
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Horton TM
      type
      Author
    2. name
      Drachtman RA
      type
      Author
    3. name
      Chen L
      type
      Author
    4. name
      Cole PD
      type
      Author
    5. name
      McCarten K
      type
      Author
    6. name
      Voss S
      type
      Author
    7. name
      Guillerman RP
      type
      Author
    8. name
      Buxton A
      type
      Author
    9. name
      Howard SC
      type
      Author
    10. name
      Hogan SM
      type
      Author
    11. name
      Sheehan AM
      type
      Author
    12. name
      López-Terrada D
      type
      Author
    bibliography ids
    1. nci-bib-facea14e0921b84a43514fb9
    book metadata
    content sha256
    e9badd141fb11be95abc16b2f6bea2019c3ab50c0dea2c2e9a28058a64edbd8a
    document type
    citation
    dois
    1. 10.1111/bjh.13388
    electronic publication date
    display
    2015 Apr 1
    precision
    day
    year
    2015
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:25833390
    immutable id
    pubmed:25833390@e9badd141fb11be95abc16b2f6bea2019c3ab50c0dea2c2e9a28058a64edbd8a
    journal
    abbreviation
    Br J Haematol
    issn electronic
    1365-2141
    issn print
    0007-1048
    issue
    1
    name
    British journal of haematology
    nlm unique id
    0372544
    pages
    118-22
    volume
    170
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      25833390
      provenance
      batch id
      74265f1b641f04cf2d05
      provider
      NCBI PubMed ESummary
      record sha256
      51ccee9f3ca139c57b0304f3db0282dbaca6a965481fd4096195959c56de11c3
      response sha256
      193df6bb6d2ac41af73dc445bf8171fe8076a8c8a5e98882a3d6a1ada428b0f0
      retrieved at
      2026-09-09T23:47:10.134322+00:00
      publication date
      display
      2015 Jul
      precision
      month
      year
      2015
      publication types
      1. Clinical Trial, Phase II
      2. Journal Article
      3. Multicenter Study
      4. Research Support, N.I.H., Extramural
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/25833390/
      title
      A phase 2 study of bortezomib in combination with ifosfamide/vinorelbine in paediatric patients and young adults with refractory/recurrent Hodgkin lymphoma: a Children's Oncology Group study.

      Preserved source evidence · Not medical advice